AbbVie (ABBV)

$103.96 1.78 (1.74%)

19:54 EST ABBV Stock Quote Delayed 30 Minutes

Volume:

Previous Close -

Market Cap 164.97B

PE Ratio 26.12

EPS 3.98

Volume (Avg. Vol.) 9.33M

Day's Range 102.58 - 104.82

52-Week Range 62.55 - 104.82

Dividend & Yield 3.59 (3.45%)

ABBV Stock Predictions, Articles, and AbbVie News

From InvestorPlace
From the Web

4 Dividend Stocks With Yields Over 5%

By Vince Martin, InvestorPlace Contributor Nov 12, 2020

Investors have burned of late chasing high-yield dividend stocks. These 4 stocks with yields more than 5% should buck that trend.

7 Stable Blue-Chip Stocks for Today’s Volatile Economy

By Divya Premkumar, InvestorPlace Contributor Nov 9, 2020

Blue-chip stocks can generate large returns over time, making for great investments in a turbulent economy. Here are my top 7 picks.

3 Biotech Stocks With Eye-Catching Pipelines

By Tezcan Gecgil, InvestorPlace Contributor Nov 2, 2020

Investing in biotech stocks may feel daunting to many investors, but these three stocks deserve to be on your watchlist.

AbbVie News: 5 Things for ABBV Investors to Know About Q3

By William White, InvestorPlace Writer Oct 30, 2020

AbbVie (ABBV) news for Friday includes results from the biopharmaceutical company's earnings report for the third quarter of 2020.

7 Cutting-Edge Biotech Stocks for Tomorrow

By Bret Kenwell, InvestorPlace Contributor Oct 28, 2020

Biotech stocks are always going to be here, in good times and bad. Let's look at a few that are worth considering on the long side.

7 Dividend Stocks To Buy For Big Returns In Your Bank Account

By Will Ashworth, InvestorPlace Contributor Oct 20, 2020

If you’re looking to generate income, here are 7 dividend stocks to buy that will deliver generous total returns over the long haul.

5 High-Yield Stocks for 5%-Plus Dividend Payouts

By Bob Ciura, Sure Dividend Oct 16, 2020

Times have been tough lately for income investors, but these high-yield stocks whose dividends are safe remain worth a second look.

7 Value Stocks To Buy in an Overvalued Market

By Josh Enomoto, InvestorPlace Contributor Oct 15, 2020

While the coronavirus has brought excitement back to the markets, it’s the contrarian who is eyeballing value stocks that stands to win in the long run.

7 Dividend Stocks Perfect for a Retiree’s Portfolio

By Chris Lau, InvestorPlace Contributor Oct 1, 2020

Chasing high yields alone will ruin an income investor’s returns, so we look at these picks that offer a balance of stability and dividend income growth.

7 Undervalued Stocks With Massive Potential

By Chris Lau, InvestorPlace Contributor Sep 21, 2020

The stock market may have forgotten about these seven undervalued stocks, but you can pick them up now on the cheap.

6 Dividend Stocks To Buy For Stable Yield And Growth Potential

By Alex Sirois Sep 17, 2020

Juicy dividends or explosive growth stocks? Most investors don't want to choose. Here are 6 dividend stocks to keep both sides happy.

Great Yield and Packed Pipeline Signal a Buy for AbbVie

By David Moadel, InvestorPlace Contributor Sep 15, 2020

Investors can still own AbbVie stock at a good price, even in the wake of a potentially lifesaving collaboration.

30 Dividend Stocks to Buy Now for 20 Years of Income Growth

By Josh Enomoto, InvestorPlace Contributor Aug 26, 2020

With a 20-year timeline, you have multiple choices for dividend stocks to buy. Here are 30 names that should do very well.

6 Marijuana Stocks to Buy That Are Sticking In the Green

By Alex Sirois Aug 25, 2020

You can find the best marijuana stocks to buy by considering their revenue rather than chasing pure hype. Here are six that fit the bill.

7 Hot Stocks to Buy Before It’s Too Late

By Chris Lau, InvestorPlace Contributor Aug 25, 2020

Hot stocks are easy to find, but if you wait too long to buy them, you will have big regrets. Buy these seven stocks before it's too late.

AbbVie Earnings: ABBV Stock Drops 2% Despite Q2 Beats

By Nick Clarkson, Web Editor Jul 31, 2020

AbbVie earnings on Friday have ABBV stock slighty lower despite the company beating EPS and revenue estimates from Wall Street.

5 High-Yield Drug Stocks That Are Undervalued With Great Upside

By Mark R. Hake, CFA Jul 24, 2020

As the market continues to deal with the pandemic, these five cheap drug stocks have solid dividend yields of 4% and almost 37% upside.

The 8 Most Reliable Blue-Chip Stocks In the Market Today

By Gregg Early, InvestorPlace Contributor Jul 23, 2020

Fortunately, with these strong blue-chip stocks, buying safety doesn’t mean you’re going to miss out on growth. Here's why.

The 7 Best Pharmaceutical Stocks That Go Beyond the Covid-19 Chase

By Louis Navellier and the InvestorPlace Research Staff, Editor, Growth Investor Jul 14, 2020

There’s a select group of pharmaceutical stocks that stand to win without even looking for a Covid-19 cure.

AbbVie Remains One of the Safest Pharma Investments You Can Make

By Louis Navellier and the InvestorPlace Research Staff, Editor, Growth Investor Jul 8, 2020

The pharmaceutical market has its ups and downs, but that doesn't mean every investment is risky as ABBV stock is a reasonably safe bet.

Cannabis Central: The Pure-Play Pot Stock Index Moved Up On Monday

From Talk Markets Nov 24, 2020

The Pure-Play Pot Stock Index went up 1.1% on Monday.14 of the 25 constituents went up, 9 went down and 2 had no change in price. In addition, 2 of the 3 index categories went up as well.

5 High-Yield Dividend Stocks to Watch

From The Motley Fool Nov 24, 2020

They're especially valuable for retirees and investors who are concerned about recession or volatility.

The Daily Biotech Pulse: Alnylam's Oxluma Snags Early FDA Approval, DBV Chief Scientific Officer To Depart, Decision Day For Liquidia

From Benzinga Nov 24, 2020

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 23) AbbVie Inc (NYSE: ABBV)...

Navellier Ratings

Total Grade

Buy

AbbVie (ABBV)

ABBV Stock Predictions, Articles, and AbbVie News

Navellier Ratings

Total Grade

Subscriber Sign in